Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?
- 7 May 2021
- journal article
- other
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (9) , 3077-3080
Abstract
HPV vaccination is recommended for U.S. adolescents at ages 11–12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination. Our national, online experiment randomized 1,263 parents of adolescents to view one of three messages about HPV vaccination recommendations or no message. Messages framed guidelines as recommending: vaccination at age 11–12; fewer doses for those who start vaccination at age 11–12; or, fewer doses for those who start vaccination before age 15. We then assessed parents’ preferred age for HPV vaccination, categorizing preferences of ≤12 years as on-time. Parents who viewed “at age 11–12” versus no message more often preferred on-time HPV vaccination (63% vs. 43%, p < .05) and did not differ from those viewing “fewer doses at age 11–12” (63% vs. 64%, p > .05). Parents who viewed “fewer doses before age 15” less often preferred on-time HPV vaccination (39%, p < .05). Recommending HPV vaccination at age 11–12 encouraged on-time vaccination, while offering fewer doses had little impact. Providers should avoid framing HPV vaccination guidelines in reference to age 15 because doing so may discourage on-time vaccination by introducing confusion about the recommended age.Keywords
Funding Information
- Centers for Disease Control and Prevention (#3U48DP005017-03S6)
- National Cancer Institute (T32 CA057726)
This publication has 15 references indexed in Scilit:
- Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization PracticesMMWR. Morbidity and Mortality Weekly Report, 2016
- Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in WomenJAMA, 2016
- “You're never really off time”: Healthcare providers' interpretations of optimal timing for HPV vaccinationPreventive Medicine Reports, 2016
- Provider communication and HPV vaccination: The impact of recommendation qualityVaccine, 2016
- Quality of Physician Communication about Human Papillomavirus Vaccine: Findings from a National SurveyCancer Epidemiology, Biomarkers & Prevention, 2015
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in WomenNew England Journal of Medicine, 2015
- Human papillomavirus vaccine initiation among 9–13-year-olds in the United StatesPreventive Medicine Reports, 2015
- HPV Vaccine Hesitancy: Findings From a Statewide Survey of Health Care ProvidersJournal of Pediatric Health Care, 2014
- Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative StudyPediatrics, 2014
- Judgment under Uncertainty: Heuristics and BiasesScience, 1974